Position in GILD
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$240,298
-$24,783 QoQ
Shares Held
1,902
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,806
of 2,266 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EVERETT HARRIS & CO /CA/ holds $616,457,307 across 12 Drug Manufacturers - General names. GILD ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
6,475,622 | $310,441,318 | |
| 2 | ABBV |
AbbVie Inc.
|
512,541 | $128,975,817 | |
| 3 | JNJ |
Johnson & Johnson
|
469,392 | $119,211,486 | |
| 4 | MRK |
Merck & Co., Inc.
|
221,036 | $28,403,126 | |
| 5 | LLY |
ELI LILLY & Co
|
8,557 | $10,263,523 | |
| 6 | AMGN |
Amgen Inc
|
23,296 | $8,435,947 | |
| 7 | PFE |
Pfizer Inc
|
283,402 | $6,824,320 | |
| 8 | NVS |
Novartis AG
|
17,363 | $2,721,129 |
All Filings in GILD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,298 | 1,902 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $265,081 | 1,902 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $233,451 | 1,902 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $211,122 | 1,902 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $224,733 | 2,027 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $229,926 | 2,052 | Shares | Sole | 2025-05-12 | |
| 2023-12-31 | $232,417 | 2,869 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $216,876 | 2,894 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $263,425 | 3,418 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $280,355 | 3,379 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $290,087 | 3,379 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||